Literature DB >> 11701717

Placental transport of leucine, phenylalanine, glycine, and proline in intrauterine growth-restricted pregnancies.

C L Paolini1, A M Marconi, S Ronzoni, M Di Noio, P V Fennessey, G Pardi, F C Battaglia.   

Abstract

L-[1-13C]Leucine, [1-13C]glycine, L-[1-13C]phenylalanine, and L-[1-13C]proline were infused as a bolus into the maternal circulation of seven appropriate for gestational age at 30.3 +/- 3.0 wk and 7 intrauterine growth-restricted pregnancies at 26.5 +/- 1.0 wk gestation to investigate placental transport in vivo. Umbilical venous samples were obtained at the time of in utero fetal blood sampling at 450 +/- 74 sec from the bolus injection. In normal pregnancies the fetal/maternal (F/M) enrichment ratios for leucine (0.76 +/- 0.06) and phenylalanine (0.77 +/- 0.06) were higher (P < 0.01) than the F/M ratios for glycine (0.18 +/- 0.04) and proline (0.22 +/- 0.02). This suggests that these two essential amino acids rapidly cross the placenta in vivo. Compared with the essentials, both glycine and proline had significantly lower F/M enrichment ratios, which were not different from each other. The results support the hypothesis that amino acids with high affinity for exchange transporters cross the placenta most rapidly. In intrauterine growth-restricted pregnancies, the F/M enrichment ratio was significantly lower (P < 0.01) for L-[1-13C]leucine (0.76 +/- 0.06 vs. 0.48 +/- 0.07) and for L-[1-13C]phenylalanine (0.77 +/- 0.06 vs. 0.46 +/- 0.07) compared with appropriate for gestational age pregnancies reflecting impaired transplacental flux. The F/M enrichment ratio did not differ for [1-13C]glycine (0.18 +/- 0.04 vs. 0.17 +/- 0.03), and L-[1-13C]proline (0.22 +/- 0.02 vs. 0.18 +/- 0.04).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11701717     DOI: 10.1210/jcem.86.11.8036

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  64 in total

Review 1.  Clinical studies linking fetal velocimetry, blood flow and placental transport in pregnancies complicated by intrauterine growth retardation (IUGR).

Authors:  Frederick C Battaglia
Journal:  Trans Am Clin Climatol Assoc       Date:  2003

2.  Chronic maternal infusion of full-length adiponectin in pregnant mice down-regulates placental amino acid transporter activity and expression and decreases fetal growth.

Authors:  Fredrick J Rosario; Michael A Schumacher; Jean Jiang; Yoshikatsu Kanai; Theresa L Powell; Thomas Jansson
Journal:  J Physiol       Date:  2012-01-30       Impact factor: 5.182

3.  Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep.

Authors:  Paul J Rozance; Gregory J Seedorf; Alicia Brown; Gates Roe; Meghan C O'Meara; Jason Gien; Jen-Ruey Tang; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-08-26       Impact factor: 5.464

4.  Prolonged amino acid infusion into intrauterine growth-restricted fetal sheep increases leucine oxidation rates.

Authors:  Sandra G Wai; Paul J Rozance; Stephanie R Wesolowski; William W Hay; Laura D Brown
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-09-11       Impact factor: 4.310

Review 5.  The impact of IUGR on pancreatic islet development and β-cell function.

Authors:  Brit H Boehmer; Sean W Limesand; Paul J Rozance
Journal:  J Endocrinol       Date:  2017-08-14       Impact factor: 4.286

6.  Metabolome Wide Association Study of serum DDT and DDE in Pregnancy and Early Postpartum.

Authors:  Xin Hu; Shuzhao Li; Piera Cirillo; Nickilou Krigbaum; ViLinh Tran; Tomoko Ishikawa; Michele A La Merrill; Dean P Jones; Barbara Cohn
Journal:  Reprod Toxicol       Date:  2019-05-15       Impact factor: 3.143

7.  Placenta: chronicle of intrauterine growth restriction.

Authors:  Jeffrey M Dicke
Journal:  F1000 Med Rep       Date:  2010-09-23

8.  Peroxisome Proliferator-Activated Receptor -β/δ, -γ Agonists and Resveratrol Modulate Hypoxia Induced Changes in Nuclear Receptor Activators of Muscle Oxidative Metabolism.

Authors:  Timothy R H Regnault; Lin Zhao; Jacky S S Chiu; Stephanie K Gottheil; Allison Foran; Siu-Pok Yee
Journal:  PPAR Res       Date:  2010-11-24       Impact factor: 4.964

9.  Leucine acutely potentiates glucose-stimulated insulin secretion in fetal sheep.

Authors:  Brit H Boehmer; Peter R Baker; Laura D Brown; Stephanie R Wesolowski; Paul J Rozance
Journal:  J Endocrinol       Date:  2020-10       Impact factor: 4.286

10.  Increased IGFBP-1 phosphorylation in response to leucine deprivation is mediated by CK2 and PKC.

Authors:  Niyati Malkani; Kyle Biggar; Majida Abu Shehab; Shawn Shun-Cheng Li; Thomas Jansson; Madhulika B Gupta
Journal:  Mol Cell Endocrinol       Date:  2015-12-28       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.